Alnylam Pharmaceuticals reports consolidated financial results for first quarter 2010

[News]

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.

More... (http://www.news-medical.net/news/20100506/Alnylam-Pharmaceuticals-reports-consolidated-financial-results-for-first-quarter-2010.aspx)